MedTrace Logo

Risk Information and Skin-cancer Education for Undergraduate Prevention

NCT03979872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2021-07-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study will be to provide undergraduate students information about skin cancer risk and prevention. The study will last between 2-3 months. Everyone in the study will be asked to answer questionnaires and receive education about skin cancer risk factors and prevention. We will follow-up with participants by phone, text messages or e-mail in between study visits

Participants will be randomly assigned to one of four groups, the group will be in is decided by chance. Participant will either be assigned to:

* A group that gets advice about what causes skin cancer and how to prevent it
* A group that gets this advice and provides a saliva sample to receive personalized skin cancer risk genetic testing results
* A group that gets this advice and receives a personalized photo that shows existing skin damage
* A group that gets this advice, receives genetic testing results, and receives a personalized photo.

Conditions

Interventions

DIAGNOSTIC_TEST

MC1R Genetic Testing

\[See arm/group descriptions\]

OTHER

Skin Cancer Education

\[See arm/group descriptions\]

DEVICE

UV Photo

\[See arm/group descriptions\]

Sponsors & Collaborators

Principal Investigators

  • Yelena Wu, PHD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-09
Primary Completion
2020-04-07
Completion
2020-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03979872 on ClinicalTrials.gov